Page last updated: 2024-08-23

paroxetine and Hormone-Dependent Neoplasms

paroxetine has been researched along with Hormone-Dependent Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kiyotani, K; Mushiroda, T; Nakamura, Y; Sasa, M; Zembutsu, H	1
Adelson, KB; Hershman, DL; Loprinzi, CL	1

Reviews

2 review(s) available for paroxetine and Hormone-Dependent Neoplasms

Article	Year
Should CYP2D6 inhibitors be administered in conjunction with tamoxifen? Expert review of anticancer therapy, 2011, Volume: 11, Issue:2 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Female; Humans; Neoplasms, Hormone-Dependent; Paroxetine; Polymorphism, Genetic; Receptors, Estrogen; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome	2011
Treatment of hot flushes in breast and prostate cancer. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7 Topics: Amines; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cimicifuga; Contraindications; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroacupuncture; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hormone Replacement Therapy; Hot Flashes; Humans; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Paroxetine; Phytotherapy; Plant Preparations; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2005

Article

Year

Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?

Expert review of anticancer therapy, 2011, Volume: 11, Issue:2

Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Female; Humans; Neoplasms, Hormone-Dependent; Paroxetine; Polymorphism, Genetic; Receptors, Estrogen; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome

2011

Treatment of hot flushes in breast and prostate cancer.

Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7

Topics: Amines; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cimicifuga; Contraindications; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroacupuncture; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hormone Replacement Therapy; Hot Flashes; Humans; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Paroxetine; Phytotherapy; Plant Preparations; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors

2005